Work

Abstract PS3-09-20: Not all pN1 ER-pos HER2-neg breast cancers are equal: why careful patient selection is key for adjuvant ribociclib

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-09-20

Authors: B. Salaets, A. Deblander, L. De Sutter, K. Van Baelen, M. Van Houdt, N. Willers, T. Baert, A. Baten, F. Derouane, G. Floris, S. Han, H. Janssen, I. Nevelsteen, C. Remmerie, A. Smeets, J. Verhoeven, Y. Van Herck, C. Van Ongeval, C. Weltens, H. Wildiers, P. Neven

Institution: Universitair Ziekenhuis Leuven

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129770776

Cites:

Cited by:

Related to: